Stock DADI DAR AL DAWA DEVELOPMENT AND INVESTMENT CO. LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Dar Al Dawa Development and Investment Co. Ltd.

Equities

DADI

JO4101211012

Pharmaceuticals

End-of-day quote Amman S.E.
Other stock markets
 06:00:00 2024-04-23 pm EDT 		5-day change 1st Jan Change
1.31 JOD -2.24% Intraday chart for Dar Al Dawa Development and Investment Co. Ltd. -5.07% -0.76%
Mar. 31 Dar Al Dawa Development and Investment Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Dar Al Dawa Development and Investment Co. Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Business Summary

Dar Al Dawa Development and Investment Company PSC is a Jordan-based pharmaceutical company, which is engaged in the manufacturing of pharmaceutical and consumer health products. The Company’s main activities are producing medical, chemical and pharmaceutical products, and importing pharmaceutical products. The Company operates an integrated network of 11 manufacturing facilities spread across Jordan, Middle East and North Africa region, as well as Romania. Its Pharmaceutical Development Unit focuses on the process developing of various dosage forms including tablets, capsules, liquids, dry suspensions, suppositories, creams, ointments, gels, parenterals, ophthalmic and nasal preparations. The Analytical Research unit engages in the analytical method development, validation, physiochemical characterization and stability studies.

Number of employees: 1,067

Sales per Business

JOD in Million2022Weight2023Weight Delta
Medicines
81.7 %
48 79.6 % 61 81.7 % +27.38%
Food and Baby Milk
18.3 %
12 20.4 % 14 18.3 % +11.12%

Sales per region

JOD in Million2022Weight2023Weight Delta
Levant and Iraq
48.8 %
29 48.8 % 37 48.8 % +23.97%
Arabian Gulf and Yemen
31.7 %
17 28.7 % 24 31.7 % +37.14%
Africa
19.2 %
13 22.2 % 14 19.2 % +7.52%
Europe and Asia
0.3 %
0 0.3 % 0 0.3 % +13.12%

Managers

Managers TitleAgeSince
Khaled Harb CEO
 Chief Executive Officer 57 22-01-14
Shadi Shaher Hamdi Saqaf Al-Hait DFI
 Director of Finance/CFO 46 -
Mohammed Al-Sous COO
 Chief Operating Officer 61 21-11-30
Ziad Yousef CTO
 Chief Tech/Sci/R&D Officer - 06-12-31
Ismail Mahmoud Ismail Khalifeh CTO
 Chief Tech/Sci/R&D Officer 53 92-12-31
Nabeeha Beraqdar SAM
 Sales & Marketing - 09-12-31
Mudar Ibrahim Qassim Al Qasim LAW
 General Counsel 46 14-11-30

Members of the board

Members of the board TitleAgeSince
Osama Munir Awad Fattaleh BRD
 Director/Board Member 58 18-03-27
Abdel-Rahim Jardaneh CHM
 Chairman 62 -
Akram Jarrab CHM
 Chairman 76 18-12-18
Munther Al-Nabulsi BRD
 Director/Board Member 46 -
Osama Mohammed Murtaza Yaish BRD
 Director/Board Member 60 18-12-18
Ramzi Raouf Jiryes Salfiti BRD
 Director/Board Member 59 -
Muhannad Akram Abdul Latif Jarab BRD
 Director/Board Member 46 18-12-18
Adnan Khalaf Hamed Al-Sawair BRD
 Director/Board Member 63 19-04-26
Farouk Abdul Halim Tahir Al-Hadidi BRD
 Director/Board Member - -
Issam Mansour Ahmed Al-Sangalawi BRD
 Director/Board Member 57 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 35,000,000 15,275,636 ( 43.64 %) 0 43.64 %

Shareholders

NameEquities%Valuation
Social Security Corp.
19.45 %
6,806,800 19.45 % 12 M JOD
Soufian Rajab Hussein Hussein
10.02 %
3,508,514 10.02 % 6 M JOD
Lina Jardaneh
4.287 %
1,500,473 4.287 % 3 M JOD
Nizar Abdel Rahim Nizar Jardaneh
4.116 %
1,440,600 4.116 % 3 M JOD
QUDS BANK LTD.
2.857 %
1,000,000 2.857 % 2 M JOD
Munther Al-Nabulsi
2.350 %
822,562 2.350 % 1 M JOD
Akram Jarrab
2.350 %
822,500 2.350 % 1 M JOD
Al-Mutana Al-Nabulsi
2.141 %
749,350 2.141 % 1 M JOD
Rawan Abdel Rahim Nizar Jardaneh
2.065 %
722,750 2.065 % 1 M JOD
Dara Abdul Rahim Nizar Jardaneh
2.061 %
721,350 2.061 % 1 M JOD

Company contact information

Dar Al Dawa Development & Investment Co. Ltd.

P. O. Box 9364

11191, Amman

+

http://www.dadgroup.com
address Dar Al Dawa Development and Investment Co. Ltd.(DADI)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
DAR AL DAWA DEVELOPMENT AND INVESTMENT CO. LTD. Stock Dar Al Dawa Development and Investment Co. Ltd.
+1.52% 66.19M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+27.92% 672B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.26% 570B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.59% 360B
MERCK & CO., INC. Stock Merck & Co., Inc.
+16.38% 321B
ABBVIE INC. Stock AbbVie Inc.
+9.39% 300B
ASTRAZENECA PLC Stock AstraZeneca PLC
+7.42% 217B
NOVARTIS AG Stock Novartis AG
+5.40% 199B
ROCHE HOLDING AG Stock Roche Holding AG
-8.63% 204B
PFIZER, INC. Stock Pfizer, Inc.
-8.58% 149B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. DADI Stock
  4. Company Dar Al Dawa Development and Investment Co. Ltd.